Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 4, 2002, Pages 699-703

  Holven, Kirsten B ^a   Aukrust, Pål ^a   Holm, Torbjørn ^a   Ose, Leiv ^a   Nenseter, Marit S ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chemokines; Folic acid; Homocysteine; Peripheral blood mononuclear cells

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; ATHEROGENESIS; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; MALE; MONONUCLEAR CELL; ONCOGENE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; CASE-CONTROL STUDIES; CHEMOKINES; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; FEMALE; FOLIC ACID; GROWTH SUBSTANCES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RANTES;

EID: 0036118126     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000013288.35930.90     Document Type: Article

References (29)

1. Homocystinemia, vascular injury and arterial thrombosis
2. Plasma homocysteine and cardiovascular disease
3. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
4. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
5. Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
6. Hyperhomocysteinemia and thrombosis
7. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase
8. Chemokines and disease
9. Chemokines, leukocytes and atherosclerosis
10. Chemokines and atherosclerosis
11. Neutrophil superoxide release and interleukin 8 in myocardial infarction: Distinction between complicated and uncomplicated states
12. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction
13. Elevated circulating levels of C-C chemokines in patients with congestive heart failure
14. CXC-chemokines, a new group of cytokines in congestive heart failure: Possible role of platelets and monocytes
15. Interaction between chemokines and oxidative stress: Possible pathogenic role in acute coronary syndromes
16. Interleukin-8 and its receptor CXCR2 in atherosclerosis
17. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice
18. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
19. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease
20. Rapid high-performance liquid chromatography assay for total homocysteine levels in human serum
21. Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: A possible role for protein kinase C
22. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis
23. Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells
24. Chemokines and atherosclerosis
25. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice
26. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: Relevance to stability of atherosclerotic plaque
27. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells
28. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice
29. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model